Blockade of the tumor-associated macrophage (TAM) scavenger receptors MARCO and IL37R reduces the number of Tregs and restores the cytotoxicity and antitumor capacity of NKs and CD8+ CTLs [143]. The gene discussed is CD8A; the disease is neoplasm.